fluorodeoxyglucose f18 has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dierks, A; Enke, JS; Gäble, A; Hirschbühl, K; Kircher, M; Lapa, C; Reitsam, NG; Schaller, T; Trepel, M; Welzel, J | 1 |
| Bonardel, G; Chargari, C; Foehrenbach, H; Le Moulec, S; Védrine, L | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Dermatitis
| Article | Year |
|---|---|
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [
Topics: Dermatitis; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Ipilimumab in cancer patients: the issue of early metabolic response.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Dermatitis; Fluorodeoxyglucose F18; Humans; Ipilimumab; Lung Neoplasms; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2013 |